Open AccessThis article is
- freely available
The Utility of Proton Beam Therapy with Concurrent Chemotherapy for the Treatment of Esophageal Cancers
Thoracic Radiation Oncology Group, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Received: 7 September 2011; in revised form: 17 October 2011 / Accepted: 20 October 2011 / Published: 28 October 2011
Abstract: The standard of care for the management of locally advanced esophageal cancers in the United States is chemotherapy combined with radiation, either definitively, or for those who could tolerate surgery, preoperatively before esophagectomy. Although the appropriate radiation dose remains somewhat controversial, the quality of the radiation delivery is critical for the treatment of esophageal cancer since the esophagus is positioned close to vital structures, such as the heart and lung. The volume and relative doses to these normal tissues affect acute and late term complications. Advances in radiation delivery from 2D to 3D conformal radiation therapy, to Intensity Modulated Radiation Therapy (IMRT) or charged particle therapy (carbon ion or proton beam therapy (PBT)), allow incremental improvements in the therapeutic ratio. This could have implications in non-cancer related morbidity for long term survivors. This article reviews the evolution in radiation technologies and the use of PBT with chemotherapy in the management of esophageal cancer.
Keywords: esophageal cancer; proton beam; IMRT; chemotherapy
Citations to this Article
Cite This Article
MDPI and ACS Style
Lin, S.H. The Utility of Proton Beam Therapy with Concurrent Chemotherapy for the Treatment of Esophageal Cancers. Cancers 2011, 3, 4090-4101.
Lin SH. The Utility of Proton Beam Therapy with Concurrent Chemotherapy for the Treatment of Esophageal Cancers. Cancers. 2011; 3(4):4090-4101.
Lin, Steven H. 2011. "The Utility of Proton Beam Therapy with Concurrent Chemotherapy for the Treatment of Esophageal Cancers." Cancers 3, no. 4: 4090-4101.